Actuate Therapeutics, Inc. (NASDAQ:ACTU) IPO
IPO
Priced at US$8.00 a share on Aug 12, 2024.
- Price
- US$8.00 a share
- Shares offered
- 2,800,000 shares of common stock
- Offering size
- US$22.4 million
- Underwriters' option
- Up to 420,000 more shares
- Listing
- ACTU on the Nasdaq Global Market
- Underwriters
- Titan Partners Group, Newbridge Securities Corporation · In the order on the cover
- Shares delivered
- On or about Aug 14, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 4, 2024 |
| Filed publicly | May 24, 2024 |
| Amended 5 times | Newest Jul 23, 2024 |
| Shares registered with an exchange | Jun 20, 2024 |
| Declared effective by the SEC | Aug 12, 2024 |
| Final prospectus, with the price | Aug 13, 2024 |
Filings
From the cover of the final prospectus (424B4) filed Aug 13, 2024